Related Experiment Video
Updated: Aug 29, 2026
Histological Quantification of Chronic Myocardial Infarct in Rats
Published on: December 11, 2016
Noninvasive risk stratification in postinfarction patients with severe left ventricular dysfunction and methodology
Wojciech Zareba1, Arthur J Moss
1Heart Research Follow-up Program, Cardiology Unit, University of Rochester, NY 14618, USA. heartwz@heart.rochester.edu
Insights
Noninvasive electrocardiology, including heart rate variability and ECG markers, helps predict sudden cardiac death risk in postinfarction patients. Analyzing these parameters offers insights into autonomic control and myocardial vulnerability for better risk stratification.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Diagnostics
Background:
- Sudden cardiac death (SCD) results from complex interactions involving myocardial substrate, autonomic imbalance, and vulnerability.
- Noninvasive electrocardiology offers tools to investigate mechanistic pathways of cardiac events.
- Existing research establishes prognostic value of heart rate variability and turbulence in postinfarction patients, but less is known about their link to SCD or arrhythmic events.
Purpose of the Study:
- To analyze multiple noninvasive electrocardiology markers simultaneously.
- To gain insight into the relative contribution of different mechanistic pathways leading to cardiac death.
- To evaluate the prognostic significance of these parameters in postinfarction patients with severe left ventricular dysfunction.
Main Methods:
- Utilized the noninvasive electrocardiology substudy of the Multicenter Automatic Defibrillator Implantation Trial II (MADIT II).
- Combined standard 12-lead electrocardiogram (ECG) with 10-minute high-resolution Holter recordings.
- Assessed parameters like heart rate variability, nonlinear dynamics, heart rate turbulence, QRS/QTc duration, conduction disturbances, late potentials, repolarization abnormalities, atrial fibrillation, ventricular premature beats, T wave alternans, and QT variability.
Main Results:
- Established prognostic value of heart rate variability and turbulence for cardiac death prediction in postinfarction patients.
- Identified electrical manifestations of myocardial substrate changes, including QRS/QTc prolongation and conduction disturbances.
- Demonstrated ECG measures reflecting myocardial vulnerability, such as frequent ventricular premature beats and T wave alternans.
Conclusions:
- Noninvasive electrocardiology parameters are crucial for understanding SCD risk.
- Simultaneous analysis of multiple ECG markers provides a comprehensive view of risk pathways.
- This approach aids in risk stratification for postinfarction patients, particularly those with severe left ventricular dysfunction.
Abstract:
Sudden cardiac death occurs as a result of a complex interplay of changes in myocardial substrate, imbalance of autonomic regulation of the heart, and myocardial vulnerability. Noninvasive electrocardiology serves as a comprehensive tool for investigating factors representing mechanistic pathways leading to cardiac events. Heart rate variability, nonlinear dynamics of heart rate, and heart rate turbulence provide insight into autonomic control of the heart. Prognostic value of these parameters in postinfarction patients is well established for predicting cardiac death, but there is less evidence for their association with sudden death or arrhythmic events. Electrical manifestation of changes in myocardial substrate include QRS and QTc prolongation, presence of conduction disturbances, presence of late potentials, abnormalities of repolarization morphology, and presence of nonsinus rhythm, namely atrial fibrillation. Electrocardiogram (ECG) measures reflecting myocardial vulnerability to arrhythmias include frequent ventricular premature beats, T wave alternans, or QT variability. Prognostic significance of these parameters is documented in studies focused mostly on them as individual markers of risk. The noninvasive electrocardiology substudy of the Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) allows for simultaneous analysis of several of the above ECG markers of risk and will provide insight about relative contribution of mechanistic pathways leading to cardiac death in postinfarction patients with severe left ventricular dysfunction. Combination of a standard 12-lead ECG and 10-minute high-resolution Holter recordings serves to evaluate the prognostic significance of noninvasive electrocardiology parameters for mortality in patients randomized to conventional treatment and for arrhythmic events in patients randomized to implantable cardioverter defibrillator therapy.
Related Concept Videos
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
01:30Acute Coronary Syndrome III: Diagnostic Studies